MedTrace Logo

Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy

NCT01530841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2017-03-10

No results posted yet for this study

Summary

Myotonic dystrophy type 1 is a myopathy with complex respiratory pattern and at risk to develop respiratory failure. Classical mode of ventilation are sometimes not tolerated or ineffective in this population. New modes of nocturnal ventilation by combining both volumetric and barometric advantages. The aim of this study is to compare effect of AVAPS mode to bilevel pressure support.

Conditions

  • Myopathy

Interventions

DEVICE

Nocturnal ventilation

Home ventilation only the mode AVAPS will be used if the patient is randomized in the experimental group.

Sponsors & Collaborators

  • Adep Assistance

    collaborator OTHER

  • Philips Respironics

    collaborator INDUSTRY

  • Centre d'Investigation Clinique et Technologique 805

    lead OTHER

Principal Investigators

  • David ORLIKOWSKI, Md-PhD · Raymond Poincare Hospital - Garches - France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01530841 on ClinicalTrials.gov